Using Artificial Intelligence to Design the Next Generation of Viral Vectors for Lifesaving Gene Therapy

Prof Ahad Rahim (primary)
UCL School of Pharmacy
University College London
Dr Stephen Goldrick (secondary)
Biochemical Engineering
University College London

Abstract

Gene therapy is revolutionising the way we treat lethal genetic diseases. Two FDA approved gene therapies are already on the market that cure genetic diseases from a single injection of viral vectors that deliver a healthy version of a defective gene to cells of the body. However, some diseases are more challenging and require better viral vectors with higher cell tropism. In this project we will use a multidisciplinary approach involving computational techniques, artificial intelligence, cell and molecular biology and animal studies to design the next generation of novel viral vectors and test these in animals.


References

Rahim AA, Gissen P. Gene therapy for global brain diseases: One small step for mice, one giant leap for humans. Brain. 2020Jul 1;143(7):1964-1966

Tordo J, O’Leary C, Antunes ASLM, Palomar N, Aldrin-Kirk P, Basche M, Bennett A, D’Souza Z, Gleitz H, Godwin A, Holley RJ, Parker H, Liao AY, Rouse P, Youshani AS, Dridi L, Martins C, Levade T, Stacey KB, Davis DM, Dyer A, Clément N, Björklund T, Ali RR, Agbandje-McKenna M, Rahim AA, Pshezhetsky A, Waddington SN, Linden RM, Bigger BW, Henckaerts E. A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency. Brain. 2018 Jul 1;141(7):2014-2031

Massaro G, Mattar CNZ, Wong AMS, Sirka E, Buckley SMK, Herbert BR, Karlsson S, Perocheau DP, Burke D, Heales S, Richard-Londt A, Brandner S, Huebecker M, Priestman DA, Platt FM, Mills K, Biswas A, Cooper JD, Chan JKY, Cheng SH, Waddington SN, Rahim AA. Fetal gene therapy for neurodegenerative disease of infants. Nature Medicine. 2018 Sep;24(9):1317-1323

Goldrick, S., Holmes, W., Bond, N., Lewis G., Kuiper, M., Turner R., Farid, S.S. (2017). Advanced multivariate data analysis to determine the root cause of trisulfide bond formation in a novel antibody-peptide fusion. Biotechnology and Bioengineering, 114, 2222-2234

Goldrick, S., Duran-Villalobos, C. A., Jankauskas, K., Lovett, D., Farid, S.S, Lennox, B. (2019). Modern day monitoring and control challenges outlined on an industrial-scale benchmark fermentation process, Computers and Chemical Engineering


BBSRC Area
Molecules, cells and industrial biotechnology
Area of Biology
BiotechnologyNeurobiology
Techniques & Approaches
BioinformaticsEngineeringMathematics / StatisticsMolecular BiologySimulation / Modelling